Bavarian Nordic Makes Deal to Provide 1.5M Monkeypox Vaccine Doses to Unnamed European Country

The Danish drugmaker Bavarian Nordic has signed a deal with another unnamed European nation, this time promising 1.5 million doses of its monkeypox vaccine. This is the second deal with undisclosed European countries and comes hot off the heels of a deal with the US govt for 2.5 million.

According to Zoey Becker, “The orders have boosted the Danish drugmaker’s revenue forecasts more than once. Recently, a 110,000-dose order from the European Health Emergency Preparedness and Response Authority (HERA) spurred an increase in the company’s revenue outlook, although it’s still expected to chart an overall loss due to R&D investments for the year.”

To read more, click here.

(Source: Fierce Pharma, July 19th, 2022)